Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). (Q46716172)
Jump to navigation
Jump to search
scientific article published on 6 March 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). |
scientific article published on 6 March 2008 |
Statements
1 reference
Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). (English)
1 reference
Salim Yusuf
1 reference
Janice Pogue
1 reference
Raffaele De Caterina
1 reference
Stefan H Hohnloser
1 reference
Marc A Pfeffer
1 reference
Jeff S Healey
1 reference
Robert G Hart
1 reference
Greg Flaker
1 reference
Stuart J Connolly
1 reference
6 March 2008
1 reference
1 reference
39
1 reference
5
1 reference
1482-1486
1 reference
Identifiers
1 reference